Acuta Capital Partners, LLC Olema Pharmaceuticals, Inc. Transaction History

Acuta Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.19 - $12.98 $386,510 - $612,565	47,193 Added 44.6%	153,007 $1.89 Million
Q2 2023 Aug 14, 2023	BUY	$3.22 - $9.65 $340,721 - $1.02 Million	105,814 New	105,814 $955,000
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $1.32 Million - $4.62 Million	-150,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.96 - $30.13 $3.46 Million - $4.53 Million	150,500 New	150,500 $4.15 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $247M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.